allergic rhinitis
Conditions
Interventions
Test group:Half dose asthma cream + simulant
Control group:Asthmatic: 6 g of asthmatic
Sponsors
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for moderate to severe Artemisia pollen allergic rhinitis; 2. Comply with the standard of TCM syndrome differentiation of spleen and lung qi deficiency; 3. The age is between 18-60 years old, and the gender is not limited; 4. The course of the disease is more than 1 year; 5. Comply with GCP regulations, sign informed consent, and voluntarily test.
Exclusion criteria
Exclusion criteria: 1) Severe nasal congestion, vasomotor rhinitis, drug-induced rhinitis, other non-allergic rhinitis, respiratory tract Patients with infection, obstructive nasal polyps, or recent upper airway surgery. 2) Fever >38?, or accompanied by other acute infections. 3) Use other Chinese and Western medicines for allergic rhinitis before entering the trial, as follows: use within 1 month Systemic or topical corticosteroids; cromoglycate within 2 weeks; decongestants within 3 days; within 10 days Use loratadine; use ciprofloxacin within 12 weeks; use other drugs that affect nasal symptoms within 3 days. 4) Those under the age of 18 or over 60, or those who are pregnant or breastfeeding. 5) Severe primary cardiovascular disease, liver disease, kidney disease, hematological disease, asthma and other lung diseases disease, or a serious disease that affects their survival, such as cancer or AIDS. 6) Legally or mentally disabled patients. 7) Lost to follow-up due to various reasons. 8) Patients with other immune system diseases and long-term medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS rating;4 nasal symptoms (sneezing, runny nose, itching, and stuffiness);2 eye symptoms (itching/foreign body sensation/redness, tears); | — |
Secondary
| Measure | Time frame |
|---|---|
| rhinoconjunctivitis quality of life questionnaire, RQLQ;Psychological state score;Cellular inflammatory factors; | — |
Countries
China
Contacts
Public ContactZhang Yu
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Outcome results
None listed